Ulcerative colitis Trials in Negrar, Italy
Conditions / Ulcerative colitis / Negrar, Italy
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06257875 | A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03290781 | An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03996369 | Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT07012395 | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis | RECRUITING | — |
| NCT03945188 | Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06052059 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03283085 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | COMPLETED | PHASE3 |
| NCT04033445 | A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT05507203 | ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 | COMPLETED | PHASE3 |